Quantitative proteomics of changes in energy metabolism-related proteins in atrial tissue from valvular disease patients with permanent atrial fibrillation

Circulation Journal

Volumn 78, Issue 4, 2014, Pages 993-1001

  Tu, Tao ^a   Zhou, Shenghua ^a   Liu, Zhenjiang ^a   Li, Xuping ^a   Liu, Qiming ^a  

^a CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

2 d liquid chromatography tandem mass spectrometry; Atrial fibrillation; Energy metabolism; Isobaric tag for relative and absolute quantification; Proteomics

Indexed keywords

DESMOPLAKIN; HEAT SHOCK PROTEIN; HEAT SHOCK PROTEIN BETA 1; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CARBOHYDRATE METABOLISM; CLINICAL ARTICLE; DOWN REGULATION; ELECTROCARDIOGRAPHY; ENERGY METABOLISM; HEART ATRIUM FIBRILLATION; HUMAN; LIPID METABOLISM; LIQUID CHROMATOGRAPHY; PROTEIN EXPRESSION; PROTEOMICS; SINUS RHYTHM; TANDEM MASS SPECTROMETRY; TRANSTHORACIC ECHOCARDIOGRAPHY; WESTERN BLOTTING;

ADULT; ATRIAL FIBRILLATION; ENERGY METABOLISM; FEMALE; HEART ATRIA; HEART VALVE DISEASES; HUMANS; MALE; MUSCLE PROTEINS; PROTEOMICS;

EID: 84897823231     PISSN: 13469843     EISSN: 13474820     Source Type: Journal    
DOI: 10.1253/circj.CJ-13-1365     Document Type: Article

References (44)

1. Naccarelli GV, Varker H, Lin J, Schulman KL. Increasing prevalence of atrial fibrillation and futter in the United States. Am J Cardiol 2009; 104: 1534-1539.
2. Friberg L, Hammar N, Rosenqvist M. Stroke in paroxysmal atrial fibrillation: A report from the Stockholm Cohort of Atrial Fibrillation. Eur Heart J 2010; 31: 967-975.
3. Wijffels MC, Kirchhof CJ, Dorland R, Allessie MA. Atrial fibrillation begets atrial fibrillation. A study in awake chronically instrumented goats. Circulation 1995; 92: 1954-1968.
4. Casaclang-Verzosa G, Gersh BJ, Tsang TS. Structural and functional remodeling of the left atrium: Clinical and therapeutic implications for atrial fibrillation. J Am Coll Cardiol 2008; 51: 1-11.
5. Allessie M, Ausma J, Schotten U. Electrical, contractile and structural remodeling during atrial fibrillation. Cardiovasc Res 2002; 54: 230-246.
6. Wakili R, Voigt N, Kääb S, Dobrev D, Nattel S. Recent advances in the molecular pathophysiology of atrial fibrillation. J Clin Invest 2011; 121: 2955-2968.
7. Murakoshi N, Aonuma K. Epidemiology of arrhythmias and sudden cardiac death in Asia. Circ J 2013; 77: 2419-2431.
8. Kalifa J, Maixent JM, Chalvidan T, Dalmasso C, Colin D, Cozma D, et al. Energetic metabolism during acute stretch-related atrial fbrilla-tion. Mol Cell Biochem 2008; 317: 69-75.
9. Barbey O, Pierre S, Duran MJ, Sennoune S, Levy S, Maixent JM. Specifc up-regulation of mitochondrial F0F1-ATPase activity after short episodes of atrial fibrillation in sheep. J Cardiovasc Electro-physiol 2000; 11: 432-438.
10. Ausma J, Coumans WA, Duimel H, Van der Vusse GJ, Allessie MA, Borgers M. Atrial high energy phosphate content and mitochondrial enzyme activity during chronic atrial fibrillation. Cardiovasc Res 2000; 47: 788-796.
11. Leistad E, Aksnes G, Verburg E, Christensen G. Atrial contractile dysfunction after short-term atrial fibrillation is reduced by verapamil but increased by BAY K8644. Circulation 1996; 93: 1747-1754.
12. Tsuboi M, Hisatome I, Morisaki T, Tanaka M, Tomikura Y, Takeda S, et al. Mitochondrial DNA deletion associated with the reduction of adenine nucleotides in human atrium and atrial fibrillation. Eur J Clin Invest 2001; 31: 489-496.
13. Cha YM, Dzeja PP, Shen WK, Jahangir A, Hart CY, Terzic A, et al. Failing atrial myocardium: Energetic defcits accompany structural remodeling and electrical instability. Am J Physiol Heart Circ Physiol 2003; 284: H1313-H1320.
14. Seppet E, Eimre M, Peet N, Paju K, Orlova E, Ress M, et al. Compart-mentation of energy metabolism in atrial myocardium of patients undergoing cardiac surgery. Mol Cell Biochem 2005; 270: 49-61.
15. Ross PL, Huang YN, Marchese JN, Williamson B, Parker K, Hattan S, et al. Multiplexed protein quantitation in Saccharomyces cerevisiae using amine-reactive isobaric tagging reagents. Mol Cell Proteomics 2004; 3: 1154-1169.
16. Lin HC, Zhang FL, Geng Q, Yu T, Cui YQ, Liu XH, et al. Quantitative analysis identifes CPNE3 as a novel metastasis-promoting gene in NSCLC. J Proteome Res 2013; 12: 3423-3433.
17. Chen J, Mandapati R, Brenfeld O, Skanes AC, Gray RA, Jalife J. Dynamics of wavelets and their role in atrial fibrillation in the isolated sheep heart. Cardiovasc Res 2000; 48: 220-232.
18. Pappone C, Oreto G, Rosanio S, Vicedomini G, Tocchi M, Gugliotta F, et al. Atrial electroanatomic remodeling after circumferential radio-frequency pulmonary vein ablation: Effcacy of an anatomic approach in a large cohort of patients with atrial fibrillation. Circulation 2001; 104: 2539-2544.
19. Miyasaka Y. Can we predict the outcome of catheter ablation for atrial fibrillation?: Role of left atrial and appendage function. Circ J 2013; 77: 1681-1683.
20. Lai LP, Lin JL, Lin CS, Yeh HM, Tsay YG, Lee CF, et al. Functional genomic study on atrial fibrillation using cDNA microarray and two-dimensional protein electrophoresis techniques and identification of the myosin regulatory light chain isoform reprogramming in atrial fibrillation. J Cardiovasc Electrophysiol 2004; 15: 214-223.
21. Voigt N, Trausch A, Knaut M, Matschke K, Varró A, Van Wagoner DR, et al. Left-to-right atrial inward rectifer potassium current gradients in patients with paroxysmal versus chronic atrial fibrillation. Circ Arrhythm Electrophysiol 2010; 3: 472-480.
22. Kourliouros A, Yin X, Didangelos A, Hosseini MT, Valencia O, Mayr M, et al. Substrate modifcations precede the development of atrial fibrillation after cardiac surgery: A proteomic study. Ann Thorac Surg 2011; 92: 104-110.
23. De Souza AI, Cardin S, Wait R, Chung YL, Vijayakumar M, Maguy A, et al. Proteomic and metabolomic analysis of atrial profbrillatory remodelling in congestive heart failure. J Mol Cell Cardiol 2010; 49: 851-863.
24. Barth AS, Merk S, Arnoldi E, Zwermann L, Kloos P, Gebauer M, et al. Reprogramming of the human atrial transcriptome in permanent atrial fibrillation: Expression of a ventricular-like genomic signature. Circ Res 2005; 96: 1022-1029.
25. Mayr M, Yusuf S, Weir G, Chung YL, Mayr U, Yin X, et al. Combined metabolomic and proteomic analysis of human atrial fbrilla-tion. J Am Coll Cardiol 2008; 51: 585-594.
26. Modrego J, Maroto L, Tamargo J, Azcona L, Mateos-Cáceres P, Segura A, et al. Comparative expression of proteins in left and right atrial appendages from patients with mitral valve disease at sinus rhythm and atrial fibrillation. J Cardiovasc Electrophysiol 2010; 21: 859-868.
27. Stanley WC, Lopaschuk GD, Hall JL, McCormack JG. Regulation of myocardial carbohydrate metabolism under normal and ischaemic conditions. Potential for pharmacological interventions. Cardiovasc Res 1997; 33: 243-257.
28. Andresen BS, Olpin S, Poorthuis BJ, Scholte HR, Vianey-Saban C, Wanders R, et al. Clear correlation of genotype with disease phenotype in very-long-chain acyl-CoA dehydrogenase defciency. Am J Hum Genet 1999; 64: 479-494.
29. Carvajal K, Moreno-Sánchez R. Heart metabolic disturbances in cardiovascular diseases. Arch Med Res 2003; 34: 89-99.
30. Raha S, Robinson BH. Mitochondria, oxygen free radicals, disease and ageing. Trends Biochem Sci 2000; 25: 502-508.
31. Capaldi RA. Structure and function of cytochrome c oxidase. Annu Rev Biochem 1990; 59: 569-596.
32. Vijayasarathy C, Biunno I, Lenka N, Yang M, Basu A, Hall IP, et al. Variations in the subunit content and catalytic activity of the cyto-chrome c oxidase complex from different tissues and different cardiac compartments. Biochim Biophys Acta 1998; 1371: 71-82.
33. Rizzuto R, Sandonà D, Brini M, Capaldi RA, Bisson R. The most conserved nuclear-encoded polypeptide of cytochrome c oxidase is the putative zinc-binding subunit: Primary structure of subunit V from the slime mold Dictyostelium discoideum. Biochim Biophys Acta 1991; 1129: 100-104.
34. Zeviani M, Sakoda S, Sherbany AA, Nakase H, Rizzuto R, Samitt CE, et al. Sequence of cDNAs encoding subunit Vb of human and bovine cytochrome c oxidase. Gene 1988; 65: 1-11.
35. Arnold S, Kadenbach B. Cell respiration is controlled by ATP: An al-losteric inhibitor of cytochrome c oxidase. Eur J Biochem 1997; 249: 350-354.
36. Bender E, Kadenbach B. The allosteric ATP-inhibition of cytochrome c oxidase activity is reversibly switched on by cAMP-dependent phos-phorylation. FEBS Lett 2000; 466: 130-134.
37. Beauchemin AM, Gottlieb B, Beitel LK, Elhaji YA, Pinsky L, Trifro MA. Cytochrome c oxidase subunit Vb interacts with human andro-gen receptor: A potential mechanism for neurotoxicity in spinobul-bar muscular atrophy. Brain Res Bull 2001; 56: 285-297.
38. Allen LA, Zhao XJ, Caughey W, Poyton RO. Isoforms of yeast cy-tochrome c oxidase subunit V affect the binuclear reaction center and alter the kinetics of interaction with the isoforms of yeast cytochrome c. J Biol Chem 1995; 270: 110-118.
39. Wu H, Rao GN, Dai B, Singh P. Autocrine gastrins in colon cancer cells up-regulate cytochrome c oxidase Vb and down-regulate effux of cytochrome c and activation of caspase-3. J Biol Chem 2000; 275: 32491-32498.
40. Spanaki C, Plaitakis A. The role of glutamate dehydrogenase in mammalian ammonia metabolism. Neurotox Res 2012; 21: 117-127.
41. Chen CH, Sun L, Mochly-Rosen D. Mitochondrial aldehyde dehy-drogenase and cardiac diseases. Cardiovasc Res 2010; 88: 51-57.
42. Machino-Ohtsuka T, Seo Y, Ishizu T, Yanaka S, Nakajima H, Atsumi A, et al. Signifcant improvement of left atrial and left atrial appendage function after catheter ablation for persistent atrial fibrillation. Circ J 2013; 77: 1695-1704.
43. Brundel BJ, Henning RH, Kampinga HH, Van Gelder IC, Crijns HJ. Molecular mechanisms of remodeling in human atrial fibrillation. Cardiovasc Res 2002; 54: 315-324.
44. Gaborit N, Steenman M, Lamirault G, Le Meur N, Le Bouter S, Lande G, et al. Human atrial ion channel and transporter subunit gene-expression remodeling associated with valvular heart disease and atrial fibrillation. Circulation 2005; 112: 471-481.